
Jyong Biotech Ltd. Ordinary Shares
MENS | NASDAQ
$1.91
+$0.03 (+1.60%)
Nov 2, 2026, 11:30 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -4.67M | -3.02M | -4.4M | -6.63M | -4.2M | -1.92M |
Depreciation & Amortization | 100K | 120K | 127K | 123K | 122K | 110K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 20.74M | -1.49M | 1.12M | 2.97M | 1.22M | 25K |
Other Non-Cash Items | -19.21M | 761K | 554K | 599K | 849K | 694K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 20.74M | -1.49M | 1.12M | 2.94M | 1.24M | 25K |
Operating Cash Flow | -3.04M | -3.62M | -2.6M | -2.97M | -1.98M | -1.09M |
Capital Expenditures | n/a | n/a | n/a | -246K | -137K | -88K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -16.87M | n/a | n/a | -292K | -1.83M | n/a |
Sales Maturities Of Investments | 16.87M | n/a | 95K | 1.93M | 664K | n/a |
Other Investing Acitivies | -13.51M | n/a | n/a | n/a | n/a | 819K |
Investing Cash Flow | -13.51M | n/a | 95K | 1.39M | -1.31M | 731K |
Debt Repayment | -24K | 2.2M | 2.47M | 3.61M | -1.35M | 2.39M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -114K | -213K | -445K | -276K | -35K | 2.52M |
Financial Cash Flow | 17.63M | 1.99M | 2.03M | 3.33M | -1.38M | 4.91M |
Net Cash Flow | 1.08M | -1.64M | -532K | 1.72M | -4.61M | 5.16M |
Free Cash Flow | -3.04M | -3.62M | -2.6M | -3.22M | -2.12M | -1.18M |
Adj. Free Cash Flow | -3.04M | -3.62M | -2.6M | -3.22M | -2.12M | -1.18M |
Maintenance CapEx | n/a | n/a | n/a | -123K | -122K | -88K |
Growth CapEx | n/a | n/a | n/a | -123K | -15K | n/a |
Owner Earnings | -3.04M | -3.62M | -2.6M | -3.09M | -2.11M | -1.18M |
Add to Watchlist
Select watchlists to add or remove MENS